Dapagliflozin Inhibits Cell Adhesion to Collagen I and IV and Increases Ectodomain Proteolytic Cleavage of DDR1 by Increasing ADAM10 Activity

Dapagliflozin, empagliflozin, tofogliflozin, selective inhibitors of sodium-glucose cotransporter 2 (SGLT2), is used clinically to reduce circulation glucose levels in patients with type 2 diabetes mellitus by blocking the reabsorption of glucose by the kidneys. Dapagliflozin is metabolized and inac...

Descripción completa

Detalles Bibliográficos
Autores principales: Okada, Junichi, Yamada, Eijiro, Saito, Tsugumichi, Yokoo, Hideaki, Osaki, Aya, Shimoda, Yoko, Ozawa, Atsushi, Nakajima, Yasuyo, Pessin, Jeffrey E., Okada, Shuichi, Yamada, Masanobu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7038111/
https://www.ncbi.nlm.nih.gov/pubmed/31979355
http://dx.doi.org/10.3390/molecules25030495

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7038111/
https://www.ncbi.nlm.nih.gov/pubmed/31979355
http://dx.doi.org/10.3390/molecules25030495

Ejemplares similares